Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Unlisted share news
  3. Anglo-French Drugs & Industries - Net Profit Declines 88.72% in June 20…

Anglo-French Drugs & Industries - Net Profit Declines 88.72% in June 2026 Quarter

13 Aug 2026

Add as preferred source
Key Takeaways

  • Anglo-French Drugs & Industries’ Q1 FY27 results highlight significant near-term pressure, with net profit falling 88.72% year-on-year to ₹3.94 crore. The key factors to watch ahead will be a recovery in operating performance and the company’s ability to rebuild sustainable earnings momentum.

  • Anglo-French Drugs & Industries’ Q1 FY27 results highlight significant near-term pressure, with net profit falling 88.72% year-on-year to ₹3.94 crore. The key factors to watch ahead will be a recovery in operating performance and the company’s ability to rebuild sustainable earnings momentum.

Anglo French Drugs and Industries Unlisted Shares

Anglo French Drugs and Industries

0.04%

Expert Analysis

Expert Analysis:

  • Anglo-French Drugs & Industries reported an 88.72% year-on-year decline in standalone net profit to ₹3.94 crore in Q1 FY27, compared with ₹34.92 crore in the June 2025 quarter.

  • The sharp decline in earnings indicates significant pressure on the company’s overall operating performance during the quarter.

  • The steep fall in profitability raises concerns around near-term earnings momentum and the company’s ability to maintain its previous level of profitability.

  • Investors will likely focus on whether the company can improve operating performance and restore stronger earnings growth in the coming quarters.

  • Sustained recovery in revenue and profitability will be important for rebuilding investor confidence following the sharp year-on-year decline.

Publisher:Business Standard